Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 49Carcinoma, Renal Cell 30Neoplasm Metastasis 18Neoplasms 15Kidney Neoplasms 14Neuroendocrine Tumors 11Carcinoma, Neuroendocrine 9Prostatic Neoplasms 7Melanoma 7Triple Negative Breast Neoplasms 6Thyroid Neoplasms 6Sarcoma 6Meningioma 6Lymphoma 6Glioma 6Endometrial Neoplasms 6Tuberous Sclerosis 5Stomach Neoplasms 5Recurrence 5Lymphoma, Mantle-Cell 5Head and Neck Neoplasms 5Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Carcinoma 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Liver Neoplasms 4Carcinoma, Islet Cell 4Astrocytoma 4

Interventions

Fluorouracil 37Radiotherapy 31Oxaliplatin 29Cisplatin 28Paclitaxel 24Leucovorin 22Irinotecan 19Docetaxel 13pembrolizumab 10Capecitabine 10Carboplatin 9Radiation 8Neoadjuvant Therapy 8Cetuximab 8Surgical Procedures, Operative 7Folfox protocol 7Chemotherapy, Adjuvant 6Nivolumab 5Gefitinib 5Taxes 4Erlotinib Hydrochloride 4Biopsy 4durvalumab 3Panitumumab 3Itraconazole 3Epirubicin 3Bevacizumab 3tremelimumab 2spartalizumab 2ixabepilone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Adenocarcinoma Of Esophagus × Everolimus × Clear all
NCT00985192 2020-08-05

Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer

Translational Oncology Research International

Phase 2 Completed
49 enrolled 13 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡